表紙
市場調査レポート

飼料用ユーバイオティクス成分の世界市場の動向・予測 〜2020年:タイプ (プロバイオティクス・プレバイオティクス・有機酸・精油)・家畜・地域別

Eubiotics Market by Type (Probiotics, Prebiotics, Organic Acids, & Essential Oils), Livestock (Pork/Swine, Poultry, Ruminant, & Aquaculture), & by Region (North America, Europe, Asia-Pacific, & Rest of the World) - Global Trends & Forecast to 2020

発行 MarketsandMarkets 商品コード 298905
出版日 ページ情報 英文 173 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
飼料用ユーバイオティクス成分の世界市場の動向・予測 〜2020年:タイプ (プロバイオティクス・プレバイオティクス・有機酸・精油)・家畜・地域別 Eubiotics Market by Type (Probiotics, Prebiotics, Organic Acids, & Essential Oils), Livestock (Pork/Swine, Poultry, Ruminant, & Aquaculture), & by Region (North America, Europe, Asia-Pacific, & Rest of the World) - Global Trends & Forecast to 2020
出版日: 2015年08月28日 ページ情報: 英文 173 Pages
概要

飼料用ユーバイオティクス成分の市場は近年、急激な成長を遂げています。今後も2015年から2020年にかけて7.4%のCAGRで推移し、2014年の46億2000万米ドルから、2020年には70億5000米万ドルの規模に成長すると予測されています。

当レポートでは、世界の飼料用ユーバイオティクス成分の市場について調査し、ユーバイオティクス成分の種類と概要、産業構造とバリューチェーン、成分・家畜区分別の市場動向および市場規模の推移と予測、地域および主要国における動向、市場成長への各種影響因子の分析、競合環境と市場シェア、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 魅力的な市場機会
  • プロバイオティクス:主要なタイプ
  • ユーバイオティクスの主要市場
  • 欧州:最大の地域市場
  • ライフサイクル分析:地域別

第5章 市場概要

  • イントロダクション
    • ユーバイオティクス成分の各種タイプ
      • プロバイオティクス
      • プレバイオティクス
      • 精油
      • 有機酸
  • 市場区分
    • タイプ別
    • 家畜別
  • 市場力学
    • 成長推進因子
    • 成長阻害因子
    • 市場機会
    • 課題
  • 法規制
    • 飼料添加物としての抗生物質
    • 抗生物質の禁止
      • 欧州
      • 韓国
      • 米国

第6章 産業動向

  • イントロダクション
  • バリューチェーン分析
  • サプライチェーン分析
  • ポーターのファイブフォース分析
  • 戦略的ベンチマーキング
    • 拡張・投資

第7章 タイプ別市場

  • イントロダクション
  • プロバイオティクス
    • ラクトバチルス
    • ビフィズス菌
  • プレバイオティクス
    • イヌリン
    • フルクトオリゴ糖 (FOS)
    • ガラクトオリゴ糖 (GOS)
  • 精油
  • 有機酸

第8章 家畜別市場

  • イントロダクション
  • 反芻動物
  • 水棲動物
  • その他

第9章 地域別市場

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • スイス
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他
  • その他
    • ブラジル
    • アルゼンチン
    • 南アフリカ
    • その他

第10章 競合環境

  • 概要
  • 市場シェア分析
  • 競合状況・動向
    • 拡張・投資
    • M&A
    • 合意・提携・ジョイントベンチャー・提携
    • 新製品の投入
    • 技術革新

第11章 企業プロファイル

  • イントロダクション
  • CHR. HANSEN A/S
  • ROYAL DSM
  • E. I. DU PONT DE NEMOURS AND COMPANY
  • CARGILL INCORPORATED
  • KEMIN INDUSTRIES INC.
  • BASF SE
  • BEHN MEYER GROUP
  • BENEO GROUP
  • NOVUS INTERNATIONAL, INC.
  • ADDCON
    • 企業概要
    • 財務動向
    • 製品・サービス
    • 戦略
    • 近年の発展動向、など

第12章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: AGI 2342

The eubiotics market in feed has been growing rapidly in the recent years and is projected to reach a market size at USD 7.05 billion by 2020. The market is primarily driven by the growing customer attention towards superior quality feed grades, ban on antibiotics used as growth promoters in the North American and European regions, and for feed supplementation to improve nutrient utilization and nutrient supply to the animals. The consumption of eubiotics is increasing significantly due to various government regulations being adopted to improve animal health.

Europe held the largest share of the eubiotics market in 2014. Currently, the eubiotics market is concentrated more in developed and developing countries, such as U.S., China, India, Japan, Australia, along with European countries. The growth is mainly due to the global increase in meat consumption and rise in concern regarding its quality and safety. The market for probiotics is projected to grow at the highest CAGR of 7.6% during the period from 2015 to 2020. The probiotics segment also accounted for the largest share of 65.47% in 2014, and is projected to be valued at USD 4.69 billion by 2020.

The eubiotics market is highly competitive with a large number of global market players. This report highlights the growth strategies adopted by the major market players between 2010 and 2015. Key industry players invest extensively in research and development initiatives to expand their product portfolios. Continuous investments in new product development, launches, and expansions have expanded the scope of the industry.

The global market is marked with intense competition due to the presence of a large number of big and small firms. New product developments, mergers & acquisitions, and expansions are the key strategies adopted by market players to ensure their growth. The market is dominated by players such as the Chr. Hansen (Denmark), Cargill Incorporated (U.S.) and ADDCON (Germany), BASF SE (Germany), Kemin Industries Inc. (U.S.), and Behn Meyer (Singapore).

In this report, the global eubiotics market is segmented into type, livestock, and region. The said market was valued at USD 4.62 billion in 2014 and is projected to grow at a CAGR of 7.4% from 2015 to 2020.

AVAILABLE CUSTOMIZATIONS

With the given market data, MarketsandMarkets offers customizations according to the company's specific scientific needs.

The following customization options are available for the report:

Product Analysis

  • Product matrix which gives a detailed comparison of product portfolio of each company

Geographic Analysis

  • Further breakdown of the Rest of Asia-Pacific eubiotics market into Malaysia, Thailand, Indonesia, and Vietnam
  • Further breakdown of the Rest of RoW eubiotics market into Argentina, Madagascar, Morocco, Chile, Peru, and Sudan

Company Information

  • Detailed analyses and profiling of additional market players (up to five)

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. STUDY SCOPE
    • 1.3.1. YEARS CONSIDERED
  • 1.4. CURRENCY CONSIDERED
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key Data from Secondary Sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key Data from Primary Sources
      • 2.1.2.2. Key Industry Insights
      • 2.1.2.3. Breakdown of Primary Interviews
  • 2.2. FACTOR ANALYSIS
    • 2.2.1. INTRODUCTION
    • 2.2.2. DEMAND-SIDE ANALYSIS
      • 2.2.2.1. Growing population and rising diversified food demand
      • 2.2.2.2. Emerging Economies: Population & Meat Demand
    • 2.2.3. SUPPLY-SIDE ANALYSIS
      • 2.2.3.1. Parent Market Analysis: Animal Feed Industry
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.5. RESEARCH ASSUMPTIONS & LIMITATIONS
    • 2.5.1. ASSUMPTIONS
    • 2.5.2. LIMITATIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ATTRACTIVE OPPORTUNITIES IN EUBIOTICS MARKET
  • 4.2. PROBIOTICS: LEADING SEGMENT BY TYPE
  • 4.3. LEADING MARKET FOR EUBIOTICS
  • 4.4. EUROPE: LARGEST EUBIOTICS MARKET
  • 4.5. LIFE CYCLE ANALYSIS: BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
    • 5.1.1. DIFFERENT TYPES OF EUBIOTICS
      • 5.1.1.1. Probiotics
      • 5.1.1.2. Prebiotics
      • 5.1.1.3. Essential oils
      • 5.1.1.4. Organic acids
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. EUBIOTICS MARKET, BY TYPE
    • 5.2.2. EUBIOTICS MARKET, BY LIVESTOCK
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Increase in meat production/consumption
      • 5.3.1.2. Rising awareness about feed quality
      • 5.3.1.3. Increasing disease outbreaks in livestock
      • 5.3.1.4. Replacing antibiotic growth promoters (AGP) with eubiotics in feed
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Regulatory structure & intervention
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Investment in research & development
      • 5.3.3.2. Exploring regional & untapped markets
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Rise in Raw Material Prices
  • 5.4. REGULATIONS
    • 5.4.1. ANTIBITOTICS AS FEED ADDITIVES
    • 5.4.2. BAN ON ANTIBIOTICS
      • 5.4.2.1. Europe
      • 5.4.2.2. South Korea
      • 5.4.2.3. U.S.

6. INDUSTRY TRENDS

  • 6.1. INTRODUCTION
  • 6.2. VALUE CHAIN ANALYSIS
  • 6.3. SUPPLY CHAIN ANALYSIS
    • 6.3.1. PROMINENT COMPANIES
    • 6.3.2. SMALL & MEDIUM ENTERPRISES
    • 6.3.3. END USERS
  • 6.4. PORTER'S FIVE FORCES ANALYSIS
    • 6.4.1. INTENSITY OF COMPETITIVE RIVALRY
    • 6.4.2. BARGAINING POWER OF SUPPLIERS
    • 6.4.3. BARGAINING POWER OF BUYERS
    • 6.4.4. THREAT OF NEW ENTRANTS
    • 6.4.5. THREAT OF SUBSTITUTES
  • 6.5. STRATEGIC BENCHMARKING
    • 6.5.1. EXPANSIONS & INVESTMENTS

7. EUBIOTICS MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. PROBIOTICS
    • 7.2.1. LACTOBACILLI
    • 7.2.2. BIFIDOBACTERIA
  • 7.3. PREBIOTICS
    • 7.3.1. INULIN
    • 7.3.2. FRUCTOOLIGOSACCHARIDES (FOS)
    • 7.3.3. GALACTO-OLIGOSACCHARIDES (GOS)
  • 7.4. ESSENTIAL OILS
  • 7.5. ORGANIC ACIDS

8. EUBIOTICS MARKET, BY LIVESTOCK

  • 8.1. INTRODUCTION
    • 8.1.1. KEY FEATURES
      • 8.1.1.1. Modulation of microflora
      • 8.1.1.2. Stimulate the immune response
      • 8.1.1.3. Metabolite excretion
  • 8.2. SWINE
    • 8.2.1. KEY FEATURES
      • 8.2.1.1. Prevent, Stimulate, and Neutralize
      • 8.2.1.2. Defence against infection
  • 8.3. POULTRY
    • 8.3.1. KEY FEATURES
      • 8.3.1.1. Growth and improved feed conversion rate
  • 8.4. RUMINANTS
  • 8.5. AQUATIC ANIMALS
  • 8.6. EUBIOTICS FOR OTHER LIVESTOCK TYPES

9. EUBIOTICS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
    • 9.2.3. MEXICO
  • 9.3. EUROPE
    • 9.3.1. U.K.
    • 9.3.2. GERMANY
    • 9.3.3. FRANCE
    • 9.3.4. ITALY
    • 9.3.5. SPAIN
    • 9.3.6. RUSSIA
    • 9.3.7. SWITZERLAND
    • 9.3.8. REST OF EUROPE
  • 9.4. ASIA-PACIFIC
    • 9.4.1. CHINA
    • 9.4.2. INDIA
    • 9.4.3. JAPAN
    • 9.4.4. AUSTRALIA
    • 9.4.5. REST OF ASIA-PACIFIC
  • 9.5. REST OF THE WORLD (ROW)
    • 9.5.1. BRAZIL
    • 9.5.2. ARGENTINA
    • 9.5.3. SOUTH AFRICA
    • 9.5.4. OTHER COUNTRIES IN ROW

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. EUBIOTICS MARKET: MARKET SHARE ANALYSIS (DEVELOPMENTS)
  • 10.3. COMPETITIVE SITUATIONS & TRENDS
    • 10.3.1. EXPANSIONS & INVESTMENTS
    • 10.3.2. MERGERS & ACQUISITIONS
    • 10.3.3. AGREEMENTS, PARTNERSHIPS, JOINT VENTURES & COLLABORATIONS
    • 10.3.4. NEW PRODUCT LAUNCHES
    • 10.3.5. INNOVATION

11. COMPANY PROFILES (Company at a Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*

  • 11.1. INTRODUCTION
  • 11.2. CHR. HANSEN A/S
  • 11.3. ROYAL DSM
  • 11.4. E. I. DU PONT DE NEMOURS AND COMPANY
  • 11.5. CARGILL INCORPORATED
  • 11.6. KEMIN INDUSTRIES INC.
  • 11.7. BASF SE
  • 11.8. BEHN MEYER GROUP
  • 11.9. BENEO GROUP
  • 11.10. NOVUS INTERNATIONAL, INC.
  • 11.11. ADDCON

*Details on company at a glance, recent financials, products & services, strategies & insights, & recent developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. COMPANY DEVELOPMENTS
    • 12.3.1. NEW PRODUCT LAUNCHES/DEVELOPMENTS
    • 12.3.2. MERGERS & ACQUISITIONS
    • 12.3.3. EXPANSIONS & INVESTMENTS
  • 12.4. INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: PER CAPITA CONSUMPTION OF MEAT
  • TABLE 2: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 3: PROBIOTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 4: PREBIOTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 5: ESSENTIAL OILS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 6: ORGANIC ACIDS MARKET SIZE, BY REGION,2013-2020 (USD MILLION)
  • TABLE 7: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 8: GLOBAL MEAT PRODUCTION MARKET SIZE, BY MEAT TYPE, 2013-2020 (KT)
  • TABLE 9: PER CAPITA PORK CONSUMPTION, BY KEY COUNTRY/REGION, 2013-2020 (KG/YEAR)
  • TABLE 10: SWINE: EUBIOTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 11: PER CAPITA POULTRY CONSUMPTION, BY KEY COUNTRY/REGION, 2013-2020(KG/YEAR)
  • TABLE 12: POULTRY: EUBIOTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: PER CAPITA BEEF CONSUMPTION, BY KEY COUNTRY/REGION, 2013-2020 (KG/YEAR)
  • TABLE 14: RUMINANTS: EUBIOTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 15: PER CAPITA FISH CONSUMPTION, BY KEY COUNTRY, 2013-2014 (KG/YEAR)
  • TABLE 16: AQUATIC ANIMALS: EUBIOTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 17: OTHER LIVESTOCK EUBIOTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: EUBIOTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: NORTH AMERICA: EUBIOTICS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 20: NORTH AMERICA: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 21: NORTH AMERICA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 22: U.S.: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 23: U.S.: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 24: CANADA: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 25: CANADA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 26: MEXICO: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 27: MEXICO: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 28: EUROPE: EUBIOTICS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 29: EUROPE: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 30: EUROPE: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 31: U.K.: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 32: U.K.: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 33: GERMANY: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 34: GERMANY: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 35: FRANCE: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 36: FRANCE: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 37: ITALY: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 38: ITALY: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 39: SPAIN: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 40: SPAIN: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 41: RUSSIA: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 42: RUSSIA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 43: SWITZERLAND: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 44: SWITZERLAND: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 45: REST OF EUROPE: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 46: REST OF EUROPE: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 47: ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 48: ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 49: ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 50: CHINA: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 51: CHINA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 52: INDIA: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 53: INDIA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 54: JAPAN: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 55: JAPAN: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 56: AUSTRALIA: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 57: AUSTRALIA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 58: REST OF ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 59: REST OF ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 60: ROW: EUBIOTICS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 61: ROW: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 62: ROW: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 63: BRAZIL: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 64: BRAZIL: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 65: ARGENTINA: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 66: ARGENTINA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 67: SOUTH AFRICA: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 68: SOUTH AFRICA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 69: OTHERS COUNTRIES IN ROW: EUBIOTICS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 70: OTHERS COUNTRIES IN ROW: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2013-2020 (USD MILLION)
  • TABLE 71: EXPANSIONS & INVESTMENTS, 2010-2015
  • TABLE 72: MERGERS & ACQUISITIONS, 2010-2015
  • TABLE 73: AGREEMENTS, PARTNERSHIPS, JOINT VENTURES & COLLABORATIONS, 2010-2015
  • TABLE 74: NEW PRODUCT LAUNCHES, 2010-2015
  • TABLE 75: BASF SE: PRODUCTS & THEIR DESCRIPTION

LIST OF FIGURES

  • FIGURE 1: EUBIOTICSMARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: POPULATION GROWTH TREND, 1961-2050
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION
  • FIGURE 7: EUBIOTICS MARKET SNAPSHOT, BY LIVESTOCK (2015 VS. 2020)
  • FIGURE 8: EUBIOTICS MARKET SIZE, BY REGION, 2015-2020 (USD MILLION)
  • FIGURE 9: EUBIOTICS MARKET SIZE, BY TYPE, 2015-2020 USD (USD MILLION)
  • FIGURE 10: EUBIOTICS MARKET SHARE (VALUE), BY REGION, 2014
  • FIGURE 11: GROWTH IN EUBIOTICS MARKET
  • FIGURE 12: PROBIOTICS PROJECTED TO BE THE LARGEST SEGMENT
  • FIGURE 13: U.S.: LARGEST MARKET FOR EUBIOTICS (2015-2020)
  • FIGURE 14: PROBIOTICS SEGMENT ACCOUNTED FOR LARGEST SHARE IN THE EUROPEAN EUBIOTICS MARKET, 2014
  • FIGURE 15: ASIA-PACIFIC REGION TO PROVIDE IMMENSE POTENTIAL OPPORTUNITIES FOR EUBIOTICS MARKET GROWTH
  • FIGURE 16: EUBIOTICS MARKET, BY TYPE
  • FIGURE 17: EUBIOTICS MARKET, BY LIVESTOCK
  • FIGURE 18: INCREASE IN MEAT PRODUCTION/CONSUMPTION DRIVING THE GROWTH OF EUBIOTICS MARKET
  • FIGURE 19: R&D CONTRIBUTES MAJOR VALUE TO OVERALL PRICE OF EUBIOTICS MARKET
  • FIGURE 20: RESEARCH ORGANIZATIONS & TECHNOLOGISTS: INTEGRAL PART OF SUPPLY CHAIN OF EUBIOTICS MARKET
  • FIGURE 21: PORTER'S FIVE FORCES ANALYSIS: EUBIOTICS MARKET
  • FIGURE 22: STRATEGIC BENCHMARKING: EXPANSIONS & INVESTMENTS
  • FIGURE 23: PROBIOTICS IS THE FASTEST GROWING SEGMENT IN EUBIOTICS MARKET
  • FIGURE 24: EUROPE IS PROJECTED TO LEAD THE PREBIOTICS MARKET IN 2020
  • FIGURE 25: EUBIOTICS MARKET SHARE (VALUE), BY LIVESTOCK, 2015-2020
  • FIGURE 26: GEOGRAPHIC SNAPSHOT (2015-2020): RAPIDLY GROWING MARKETS ARE EMERGING AS NEW HOTSPOTS
  • FIGURE 27: NORTH AMERICAN EUBIOTICS MARKET: A SNAPSHOT, 2014
  • FIGURE 28: EUROPEAN EUBIOTICS MARKET: A SNAPSHOT, 2014
  • FIGURE 29: CHINA WAS THE MARKET LEADER IN THE ASIA-PACIFIC REGION IN 2014
  • FIGURE 30: EXPANSIONS AND INVESTMENTS: LEADING APPROACH OF KEY PLAYERS
  • FIGURE 31: EUBIOTICS MARKET SHARE (DEVELOPMENTS), BY COMPANY, 2010-2015
  • FIGURE 32: EXPANSIONS, INVESTMENTS, FUELED GROWTH OF EUBIOTICS MARKET BETWEEN 2010 TO 2015
  • FIGURE 33: EXPANSIONS AND INVESTMENTS: THE KEY STRATEGY, 2010-2015
  • FIGURE 34: GEOGRAPHICAL REVENUE MIX OF TOP 5 MARKET PLAYERS
  • FIGURE 35: CHR. HANSEN A/S: COMPANY SNAPSHOT
  • FIGURE 36: CHR. HANSEN A/S: SWOT ANALYSIS
  • FIGURE 37: ROYAL DSM : COMPANY SNAPSHOT
  • FIGURE 38: DSM N. V.: SWOT ANALYSIS
  • FIGURE 39: E. I. DU PONT DE NEMOURS AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 40: E. I. DU PONT DE NEMOURS AND COMPANY: SWOT ANALYSIS
  • FIGURE 41: CARGILL INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 42: CARGILL INCORPORATED: SWOT ANALYSIS
  • FIGURE 43: KEMIN INDUSTRIES INC.: SWOT ANALYSIS
  • FIGURE 44: BASF SE: COMPANY SNAPSHOT
  • FIGURE 45: BASF SE: SWOT ANALYSIS
Back to Top